Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028754966> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3028754966 endingPage "524" @default.
- W3028754966 startingPage "520" @default.
- W3028754966 abstract "Objective To observe the efficacy of intravitreal injection of ranibizumab (Lucentis) and combination treatments of photodynamic therapy (PDT) and intravitreal injection of ranibizumab for exudative age-related macular degeneration (eAMD).Methods Thirty eyes from 30 patients with eAMD were enrolled in this study.Fifteen eyes were treated with intravitreal injection of ranibizumab (ranibizumab group),while 15 eyes were treated with combination treatments of PDT and intravitreal injection of ranibizumab (combination group).The follow-up ranged from 6 to 17 months with a mean of 12.5 months.The patients in ranibizumab group received intravitreal injection of ranibizumab (0.5 mg) once a month for 12 consecutive months.Follow-up visits were performed monthly after the first injection.The patients in the combination group received intravitreal injection of ranibizumab (0.5 mg) within 24 hours after PDT.Then the same dose of intravitreal injection was given the 2nd and 3rd months.They were examined on follow-up visits monthly after the 3rd injection.Injections were repeated if necessary during follow-up period.The mean number of repetitive intravitreal injections of ranibizumab was (3.7 ± 1.0) times/eye.Changes in best corrected visual acuity (BCVA),results of optic coherence tomography (OCT),fundus fluorescein angiography (FFA) and MP-1,injection times and complications were observed.Results The 1st,3rd,6th and 12th month after treatment,the average improvement value in mean light sensitivity (MS)were 1.9,3.8,5.0 and 5.5 dB in ranibizumab group; 2.0,4.2,3.7 and 4.8 dB in combination group respectively.The difference between two groups was not statistically significant (P＞0.05).The differences of improvement in BCVA and OCT between two groups also were not statistically significant (P＞0.05).The MS has positive relationship with BCVA (r =0.660,P ＜ 0.05 ).No complications such as endophthalmitis,retinal pigment epithelial tear or vitreous hemorrhage were observed during the follow-up period.Conclusions Both intravitreal injection of ranibizumab and combination treatments of PDT and intravitreal injection of ranibizumab are effective for eAMD.Combination of PDT and ranibizumab therapy decreases the frequency of retreatment.Key words: Macular degeneration/therapy; Choroidal neovascularization/therapy; Antibodies,monoclonal/therapeutic use; Photochemotherapy" @default.
- W3028754966 created "2020-06-05" @default.
- W3028754966 creator A5064709911 @default.
- W3028754966 creator A5082077159 @default.
- W3028754966 creator A5083880615 @default.
- W3028754966 date "2011-11-25" @default.
- W3028754966 modified "2023-09-23" @default.
- W3028754966 title "Combination treatments of photodynamic therapy and intravitreal anti-vascular endothelial growth factor drugs for exudative age-related macular degeneration" @default.
- W3028754966 doi "https://doi.org/10.3760/cma.j.issn.1005-1015.2011.06.005" @default.
- W3028754966 hasPublicationYear "2011" @default.
- W3028754966 type Work @default.
- W3028754966 sameAs 3028754966 @default.
- W3028754966 citedByCount "0" @default.
- W3028754966 crossrefType "journal-article" @default.
- W3028754966 hasAuthorship W3028754966A5064709911 @default.
- W3028754966 hasAuthorship W3028754966A5082077159 @default.
- W3028754966 hasAuthorship W3028754966A5083880615 @default.
- W3028754966 hasConcept C118487528 @default.
- W3028754966 hasConcept C141071460 @default.
- W3028754966 hasConcept C178790620 @default.
- W3028754966 hasConcept C185592680 @default.
- W3028754966 hasConcept C2776391266 @default.
- W3028754966 hasConcept C2776403814 @default.
- W3028754966 hasConcept C2776694085 @default.
- W3028754966 hasConcept C2777802072 @default.
- W3028754966 hasConcept C2778257484 @default.
- W3028754966 hasConcept C2780248432 @default.
- W3028754966 hasConcept C2781100027 @default.
- W3028754966 hasConcept C2781323092 @default.
- W3028754966 hasConcept C2781359195 @default.
- W3028754966 hasConcept C71924100 @default.
- W3028754966 hasConceptScore W3028754966C118487528 @default.
- W3028754966 hasConceptScore W3028754966C141071460 @default.
- W3028754966 hasConceptScore W3028754966C178790620 @default.
- W3028754966 hasConceptScore W3028754966C185592680 @default.
- W3028754966 hasConceptScore W3028754966C2776391266 @default.
- W3028754966 hasConceptScore W3028754966C2776403814 @default.
- W3028754966 hasConceptScore W3028754966C2776694085 @default.
- W3028754966 hasConceptScore W3028754966C2777802072 @default.
- W3028754966 hasConceptScore W3028754966C2778257484 @default.
- W3028754966 hasConceptScore W3028754966C2780248432 @default.
- W3028754966 hasConceptScore W3028754966C2781100027 @default.
- W3028754966 hasConceptScore W3028754966C2781323092 @default.
- W3028754966 hasConceptScore W3028754966C2781359195 @default.
- W3028754966 hasConceptScore W3028754966C71924100 @default.
- W3028754966 hasIssue "06" @default.
- W3028754966 hasLocation W30287549661 @default.
- W3028754966 hasOpenAccess W3028754966 @default.
- W3028754966 hasPrimaryLocation W30287549661 @default.
- W3028754966 hasRelatedWork W1973041406 @default.
- W3028754966 hasRelatedWork W2058075154 @default.
- W3028754966 hasRelatedWork W2088847369 @default.
- W3028754966 hasRelatedWork W2276207462 @default.
- W3028754966 hasRelatedWork W2349219630 @default.
- W3028754966 hasRelatedWork W2600874963 @default.
- W3028754966 hasRelatedWork W2742101666 @default.
- W3028754966 hasRelatedWork W2793604614 @default.
- W3028754966 hasRelatedWork W2933483331 @default.
- W3028754966 hasRelatedWork W3014502662 @default.
- W3028754966 hasRelatedWork W3028784775 @default.
- W3028754966 hasRelatedWork W3029724058 @default.
- W3028754966 hasRelatedWork W3030129633 @default.
- W3028754966 hasRelatedWork W3030241742 @default.
- W3028754966 hasRelatedWork W3030336916 @default.
- W3028754966 hasRelatedWork W3030480063 @default.
- W3028754966 hasRelatedWork W3030916835 @default.
- W3028754966 hasRelatedWork W3032672446 @default.
- W3028754966 hasRelatedWork W3032690360 @default.
- W3028754966 hasRelatedWork W3032755560 @default.
- W3028754966 hasVolume "27" @default.
- W3028754966 isParatext "false" @default.
- W3028754966 isRetracted "false" @default.
- W3028754966 magId "3028754966" @default.
- W3028754966 workType "article" @default.